tiprankstipranks

John E. Bishop Insider Profile

11 Followers
John E. Bishop, SVP, Pharmaceutical Scie at Momenta Pharma, holds 336.85K shares in Ardelyx (Ticker: ARDX), holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX), holds 93.52K shares in Momenta Pharma (Ticker: MNTA). Most recently, John E. Bishop Sold ― shares of Ardelyx on May 22, 2026 for an estimated value of $14.44K.
tipranks
John E. Bishop

John E. Bishop
Momenta Pharma (MNTA)
SVP, Pharmaceutical Scie

Ranked #47,589 out of 108,136 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+11.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of John E. Bishop's holdings

Insider Roles

Ardelyx
(ARDX)
Chief Technical and Quality Officer
Lyra Therapeutics
(LYRA)
CTO
Roles that John E. Bishop holds in companies

Most Profitable Insider Trade

Stock:
Ardelyx
(ARDX)
Rating:Informative Sell
Date:May 22, 2026 - Today
Return:+13.70%
The most profitable trade made by John E. Bishop

John E. Bishop's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MNTA
Momenta Pharma
May 23, 2016
Uninformative Sell
8.00K
$4.91M
FMTX
Forma Therapeutics Holdings
Oct 14, 2022
Uninformative Sell
$0.00
Lyra Therapeutics
CTO
Ardelyx
May 22, 2026
Chief Technical and Quality Officer
Informative Sell
14.44K
$1.78M
List of latest transactions for each holding click on a transaction to see John E. Bishop's performance on stock

John E. Bishop insider profile FAQ

What is the percentage of profitable transactions made by John E. Bishop?
The percentage of profitable transactions made by John E. Bishop is 100%.
    What is the average return per transaction made by John E. Bishop?
    The average return per transaction made by John E. Bishop is 11.00%.
      What stocks does John E. Bishop hold?
      John E. Bishop holds: MNTA, FMTX, LYRA, ARDX stocks.
        What was John E. Bishop’s latest transaction?
        John E. Bishop latest transaction was an Informative Sell of $14.44K.
          What was John E. Bishop's most profitable transaction?
          John E. Bishop’s most profitable transaction was an Informative Sell of ARDX stock on May 22, 2026. The return on the trade was 13.70%.
            What is John E. Bishop's role in Momenta Pharma?
            John E. Bishop's role in Momenta Pharma is SVP, Pharmaceutical Scie.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.